Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Hasegawa

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Advances in Experimental Medicine and Biology|January 12, 2021
Tau Protein and Frontotemporal DementiasMichel Goedert, Maria Grazia Spillantini, Benjamin Falcon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2025
NFE2L1/Nrf1 forms a coactivator complex post-peptide:<i>N</i>-glycanase-mediated sequence editing and mitigates proteasome dysfunctionYukiko Yoshida, Meari Okada, Naoko Arai, et al.
Acta Neuropathologica|June 29, 2006
Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytesKenji Sakai, Yue-Shan Piao, Koki Kikugawa, et al.
Brain : a Journal of Neurology|September 13, 2021
Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoformsMasato Hosokawa, Masami Masuda-Suzukake, Hiroshi Shitara, et al.
The Journal of Biological Chemistry|April 30, 2009
Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant TauKensuke Yotsumoto, Taro Saito, Akiko Asada, et al.
FEBS Letters|September 18, 2007
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathiesAasami Ishii, Takashi Nonaka, Sayuri Taniguchi, et al.
Brain Pathology (Zurich, Switzerland)|March 23, 2021
Progression of phosphorylated α-synuclein in Macaca fuscataIto Kawakami, Atsuko Motoda, Masashi Hashimoto, et al.
Annals of Clinical and Translational Neurology|December 2, 2024
Cerebral hypoperfusion reduces tau accumulationGhupurjan Gheni, Mitsuru Shinohara, Masami Masuda-Suzukake, et al.
Brain Pathology (Zurich, Switzerland)|April 16, 2020
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseasesTomoko Miki, Osamu Yokota, Takashi Haraguchi, et al.
Scientific Reports|August 30, 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseasePenelope G Foulds, Peter Diggle, J Douglas Mitchell, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Advances in Experimental Medicine and Biology|January 12, 2021
Tau Protein and Frontotemporal DementiasMichel Goedert, Maria Grazia Spillantini, Benjamin Falcon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2025
NFE2L1/Nrf1 forms a coactivator complex post-peptide:<i>N</i>-glycanase-mediated sequence editing and mitigates proteasome dysfunctionYukiko Yoshida, Meari Okada, Naoko Arai, et al.
Acta Neuropathologica|June 29, 2006
Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytesKenji Sakai, Yue-Shan Piao, Koki Kikugawa, et al.
Brain : a Journal of Neurology|September 13, 2021
Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoformsMasato Hosokawa, Masami Masuda-Suzukake, Hiroshi Shitara, et al.
The Journal of Biological Chemistry|April 30, 2009
Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant TauKensuke Yotsumoto, Taro Saito, Akiko Asada, et al.
FEBS Letters|September 18, 2007
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathiesAasami Ishii, Takashi Nonaka, Sayuri Taniguchi, et al.
Brain Pathology (Zurich, Switzerland)|March 23, 2021
Progression of phosphorylated α-synuclein in Macaca fuscataIto Kawakami, Atsuko Motoda, Masashi Hashimoto, et al.
Annals of Clinical and Translational Neurology|December 2, 2024
Cerebral hypoperfusion reduces tau accumulationGhupurjan Gheni, Mitsuru Shinohara, Masami Masuda-Suzukake, et al.
Brain Pathology (Zurich, Switzerland)|April 16, 2020
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseasesTomoko Miki, Osamu Yokota, Takashi Haraguchi, et al.
Scientific Reports|August 30, 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseasePenelope G Foulds, Peter Diggle, J Douglas Mitchell, et al.
Pageof 29